Menu UF Health Home Menu
 

Content Tagged Michael Haller Subscribe to RSS Feed

Haller-Michael_2907_Kiewel

Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial

Published: Jan 5th, 2016

UFDI Investigator Michael Haller, M.D. and collaborators found that among overweight adolescents with type 1 diabetes, the addition of metformin to insulin did not improve glycemic control after 6 months.

Haller-Michael_2907_Kiewel

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

Published: Dec 21st, 2015

UFDI Investigator Michael Haller, M.D. and other researchers found that intranasal glucagon was highly effective in treating insulin-induced hypoglycemia in adults with type 1 diabetes.

Haller-Michael_2907_Kiewel

Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial

Published: Dec 2nd, 2015

UFDI Investigator Michael Haller, M.D. and other researchers found that among overweight adolescents with type 1 diabetes, the addition of metformin to insulin did not improve glycemic control after 6 […]

Haller-Michael_2907_Kiewel

Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes

Published: Oct 18th, 2015

UFDI investigators and collaborators found that granulocyte colony stimulating factor monotherapy did not affect C-peptide production, HbA1c, or insulin dose.This study supports the continued exploration of G-CSF and other mobilizing […]

VideoChat

Live interview with UFDI Investigator Michael Haller, M.D. via TrialNet

Published: Sep 28th, 2015

Dr. Haller currently serves as the Principal Investigator for the TrialNet ATG/GCSF study funded collaboratively by the NIH, the Helmsley Trust, and Sanofi.

LogoText

UF type 1 diabetes research review highlights screening and study opportunities

Published: Sep 25th, 2015

Giovanna Beauchamp, M.D. and Michael J. Haller, M.D., M.S. recently released a review of several type 1 diabetes (T1D) prevention studies in Current Diabetes Reports. The publication, titled ‘Can We […]

LogoText

Screening for T1D risk to reduce DKA is not economically viable

Published: Sep 25th, 2015

Several studies have documented reduced incidence of diabetic ketoacidosis (DKA) in new-onset T1D when high-risk children are identified at an early age. As a result, researchers have questioned whether T1D […]

LogoText

New Onset T1D Study: Pancreatic Volume in Preclinical Type 1 Diabetes

Published: Sep 24th, 2015

UF researchers are seeking to determine differences in pancreatic volume between new-onset Type 1 Diabetes (T1D) patients, antibody positive subjects at increased risk for T1D, and healthy controls. The study […]

LogoText

UF researchers release publication on the influence of type 1 diabetes on pancreatic weight

Published: Sep 13th, 2015

UFDI faculty and a University of Miami researcher found that “reduced pancreas weight allows for comparisons across a wide range of donor ages by eliminating confounding variables.”

Haller-Michael_2907_Kiewel

Combination therapy for diabetes

Published: Feb 18th, 2015

Results from a UF Health pilot study have led to a new national trial investigating a combination treatment for individuals newly diagnosed with Type 1 diabetes.